Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy

References

• Borch-Johnsen K, Andersen P K, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590–6
   PubMed Web of Science ®Google Scholar
• Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651–4
   PubMed Web of Science ®Google Scholar
• Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–10
   PubMed Web of Science ®Google Scholar
• Rosenberg A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248–51
   PubMedGoogle Scholar
• Rhoads G G, Dahlen G, Berg K, Morton N E, Dannenberg A L. Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction. JAMA 1986; 256: 2540–4
   PubMed Web of Science ®Google Scholar
• Berg K, Dahlen G, Frick M H. Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230–5
   PubMed Web of Science ®Google Scholar
• Wiklund O, Angelin B, Olofsson S-O, Eriksson M, Fager G, Berglund L, Bondjers G. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet 1990; 335: 1360–3
   PubMed Web of Science ®Google Scholar
• Hassted S J, Williams R R. Three alleles for quantitative Lp(a). Genet Epidemiol 1986; 3: 53–5
   PubMed Web of Science ®Google Scholar
• Rath M, Niendorf A, Reblin T, Dietel M, Krebber H-J, Beisiegel U. Detection and quantitation of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989; 9: 579–92
   PubMedGoogle Scholar
• Jenkins A J, Steele J S, Janus E D, Best J D. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 1991; 40: 787–90
   PubMed Web of Science ®Google Scholar
• Kapelrud H, Bangsted H-J, Dahl-Jørgensen K, Berg K, Hansen K F. Serum Lp(a) lipoprotein concentrations in insulin-dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 675–8
   PubMed Web of Science ®Google Scholar
• Winocour P H, Bhatnagar D, Ishola M, Arrol S, Durrington P N. Lipoprotein (a) and microvascular disease in Type 1 (insulin-dependent) diabetes. Diabetic Med 1991; 8: 922–7
   PubMed Web of Science ®Google Scholar
• Wiinberg N, Nygardt J, Sengeløv H, Nielsen P E. Oscillometric measurement of the blood pressure. Ugeskr Laeger 1988; 150: 1282–4
   PubMedGoogle Scholar
• Kattermann R, Jaworek D, Möller G. Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 1984; 22: 245–51
   PubMedGoogle Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Goldstein D E, Peth S B, England J D, Randall L H, DaCosta J. Effects of acute changes in blood glucose in HbA1c. Diabetes 1980; 29: 623–8
   PubMed Web of Science ®Google Scholar
• Andersen I, Hannibal S. Analytical and economical optimization of a glucose method with immobilized enzymes. J Automatic Chemistry 1983; 4: 188–92
   Google Scholar
• Ullmann R, Bonitz K. Vollmechanisierte kinetische Messung von Kreatinin. Med Labor Bd 1976; 29: 137–45
   Google Scholar
• Christensen C, Ørskov C. Rapid screening PEG radioimmunoassay for quantitation of pathological microalbuminuria. Diabetic Nephropathy 1984; 3: 92–4
   Google Scholar
• Dagen M M, Packard C J, Shephard J. A comparison of commercial kits for the measurement of lipoprotein(a). Ann Clin Biochem 1991; 28: 359–64
   PubMed Web of Science ®Google Scholar
• Karádi I, Romics L, Pálos G, Domán J, Kaszás I, Hesz Á, Kostner G M. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989; 35: 2121–3
   PubMed Web of Science ®Google Scholar
• Kostner G, Klein G, Krempler F. Ug and/or diet. Treatment of hyperlipoproteinaemia, LA Carlsson, AG Olsson. Raven Press, New York 1984; 151–6
   Google Scholar
• Carlson L A, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989; 226: 271–6
   PubMed Web of Science ®Google Scholar
• Noma A, Maeda S, Okuno M, Abe A, Muto Y. Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocophenyl nicotinate. Atherosclerosis 1990; 84: 213–7
   PubMedGoogle Scholar
• Thiery J, Armstrong V W, Schleef J, Creutzfeldt C, Creutzfeldt W, Seidel D. Serum lipoprotein(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr 1988; 66: 462–3
   PubMedGoogle Scholar
• Kostner G M, Karádi I. Lipoprotein alterations in diabetes mellitus. Diabetologia 1988; 31: 717–22
   PubMedGoogle Scholar
• Winocour P H, Durrington P N, Ishola M, Anderson D C, Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1648–51
   PubMedGoogle Scholar
• Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987; 30: 144–8
   PubMed Web of Science ®Google Scholar
• Dunn F L. Hyperlipidemia in diabetes mellitus. Diabetes/Metabolism Reviews 1990; 6: 47–61
   PubMedGoogle Scholar
• Betteridge D J. Lipids, diabetes, and vascular disease. The time to act. Diabetic Med 1989; 6: 195–218
   PubMed Web of Science ®Google Scholar
• Gall M-A, Rossing P, Skøtt P, Hommel E, Mathiesen E R, Gerdes L U, Lauritzen M, Vølund A, Færgemann O, Beck-Nielsen H, Parving H-H. Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension. Am J Hypert 1992; 5: 257–65
   PubMed Web of Science ®Google Scholar
• Moorhead J F, El-Nahas M, Chan M K, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; ii: 1309–11
   Google Scholar
• Jones S L, Close C F, Mattock M B, Jarrett R J, Keen H, Viberti G C. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487–90
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Dikkeschei L D, Doorenbos H. Alterations in serum lipids and lipoproteins in male Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1989; 32: 685–9
   PubMed Web of Science ®Google Scholar